Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 McNEIL-PPC Acquires J&J-Merck Consumer J | Contract Pharma

What are you searching for?

Sign in
Breaking News

McNEIL-PPC Acquires J&J-Merck Consumer J

Enhances presence in the U.S. and Canada for digestive health products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

McNEIL-PPC, Inc. and its affiliate McNeil MMP, LLC have completed the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. joint venture in the U.S. from Merck Sharp & Dohme Corp. The joint venture will be renamed McNeil Consumer Pharmaceuticals Co. and will continue to market products under the Pepcid, Mylanta, and Mylicon brands.

In addition, Johnson & Johnson Inc., through its McNeil Consumer Healthcare Division, has acquired from Merck Canada Inc. its partnership interest in the Canadian joint venture. McNeil Canada will continue to market and sell Pepcid, 222 and Fleet Enema in Canada.

The Lancaster, PA manufacturing facility will also transfer to McNEIL-PPC, Inc. These acquisitions provide McNeil and McNeil Canada with enhanced presence in the U.S. and Canada in the digestive health category.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters